Spain: Health Cover Debate Reopens

13 February 1995

Angeles Amador, Spain's Minister for Health and Consumption, has made moves to reopen the debate on private insurance.

The bill on supervision of private insurance was passed by the Council of ministers last month, but now various ministries are expressing discontent with it. Ms Amador opposes various parts of the bill which, depending on the economy ministry, could force the debate's reopening by the general directorate for insurance. The Spanish newspaper Cinco Dias says it has been informed that the objections follow deputy prime minister Narcis Serra's decision to push for approval without the final text having been agreed after recommendations from the State Council, the Social and Economy Council and others.

Ms Amador's objections focus on the formula for agreement between Social Security and insurers in relation to health cover.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight